BACKGROUND: Sessile or nonpolypoid neoplastic lesions, including sessile serrated adenomas (SSAs), are difficult to detect in patients with inflammatory bowel disease (IBD). OBJECTIVES: To assess the prevalence and endoscopic features of SSA in IBD patients undergoing surveillance colonoscopy using novel endoscopic techniques. METHODS: Histology results of biopsies from a cohort of 87 patients (47 men; median age 51.4 years; median duration of disease 16.9 years; ulcerative colitis [n=40], Crohn disease [n=43], ischemic colitis [n=4]) with longstanding colonic IBD undergoing surveillance colonoscopy were reviewed. Lesions of dysplasia (adenoma-like mass, or dysplasia-associated lesion or mass), SSAs, adenoma-like polyps, hyperplastic polyps and inflammatory polyps were identified. Surveillance colonoscopy using high-definition alone, or with iScan (Pentax, USA) dye-sprayed or virtual chromoendoscopy was performed. Lesion characteristics were described before histological diagnosis. RESULTS: Fourteen SSAs were detected in 87 (11%) IBD patients. The endoscopic characteristics of SSA lesions were: nonpolypoid appearance (86%), predominant localization in the proximal colon (79%), >6 mm in size (79%), cloudy cover (64%), Kudo pit pattern modified type IIO (86%) and irregular spiral vascular pattern (79%). Among the 44 SSAs and hyperplastic polyps found in the present study, the above characteristics of SSA at colonoscopy had a sensitivity of 92.86% (95% CI 66.06% to 98.8%) and specificity of 93.33% (95% CI 77.89% to 98.99%) in predicting a histological diagnosis of SSA (positive predictive value 86.67%, negative predictive value 96.55%). CONCLUSION: SSAs are a common finding at surveillance colonoscopy in IBD and have several characteristic features. Further studies are needed to evaluate the natural history of these lesions in IBD patients.
BACKGROUND: Sessile or nonpolypoid neoplastic lesions, including sessile serrated adenomas (SSAs), are difficult to detect in patients with inflammatory bowel disease (IBD). OBJECTIVES: To assess the prevalence and endoscopic features of SSA in IBD patients undergoing surveillance colonoscopy using novel endoscopic techniques. METHODS: Histology results of biopsies from a cohort of 87 patients (47 men; median age 51.4 years; median duration of disease 16.9 years; ulcerative colitis [n=40], Crohn disease [n=43], ischemic colitis [n=4]) with longstanding colonic IBD undergoing surveillance colonoscopy were reviewed. Lesions of dysplasia (adenoma-like mass, or dysplasia-associated lesion or mass), SSAs, adenoma-like polyps, hyperplastic polyps and inflammatory polyps were identified. Surveillance colonoscopy using high-definition alone, or with iScan (Pentax, USA) dye-sprayed or virtual chromoendoscopy was performed. Lesion characteristics were described before histological diagnosis. RESULTS: Fourteen SSAs were detected in 87 (11%) IBD patients. The endoscopic characteristics of SSA lesions were: nonpolypoid appearance (86%), predominant localization in the proximal colon (79%), >6 mm in size (79%), cloudy cover (64%), Kudo pit pattern modified type IIO (86%) and irregular spiral vascular pattern (79%). Among the 44 SSAs and hyperplastic polyps found in the present study, the above characteristics of SSA at colonoscopy had a sensitivity of 92.86% (95% CI 66.06% to 98.8%) and specificity of 93.33% (95% CI 77.89% to 98.99%) in predicting a histological diagnosis of SSA (positive predictive value 86.67%, negative predictive value 96.55%). CONCLUSION: SSAs are a common finding at surveillance colonoscopy in IBD and have several characteristic features. Further studies are needed to evaluate the natural history of these lesions in IBD patients.
Authors: Ana Ignjatovic; James E East; Venkat Subramanian; Noriko Suzuki; Thomas Guenther; Nicky Palmer; Paul Bassett; Krish Ragunath; Brian P Saunders Journal: Am J Gastroenterol Date: 2012-06 Impact factor: 10.864
Authors: Gauree Gupta Konijeti; Mark G Shrime; Ashwin N Ananthakrishnan; Andrew T Chan Journal: Gastrointest Endosc Date: 2013-11-18 Impact factor: 9.427
Authors: Yark Hazewinkel; Maria López-Cerón; James E East; Amit Rastogi; Maria Pellisé; Takeshi Nakajima; Susanne van Eeden; Kristien M A J Tytgat; Paul Fockens; Evelien Dekker Journal: Gastrointest Endosc Date: 2013-02-21 Impact factor: 9.427
Authors: Shannon R Payne; Timothy R Church; Michael Wandell; Thomas Rösch; Neal Osborn; Dale Snover; Robert W Day; David F Ransohoff; Douglas K Rex Journal: Clin Gastroenterol Hepatol Date: 2013-12-10 Impact factor: 11.382
Authors: D H Johnson; S Khanna; T C Smyrk; E V Loftus; K S Anderson; D W Mahoney; D A Ahlquist; J B Kisiel Journal: Aliment Pharmacol Ther Date: 2014-04-30 Impact factor: 8.171
Authors: Maurice W M D Lutgens; Martijn G H van Oijen; Geert J M G van der Heijden; Frank P Vleggaar; Peter D Siersema; Bas Oldenburg Journal: Inflamm Bowel Dis Date: 2013 Mar-Apr Impact factor: 5.325
Authors: Marios Efthymiou; Patrick B Allen; Andrew C F Taylor; Paul V Desmond; Chatura Jayasakera; Peter De Cruz; Michael A Kamm Journal: Inflamm Bowel Dis Date: 2013-09 Impact factor: 5.325
Authors: Yiwei Wang; Dan Huang; Kai-Yuan Chen; Min Cui; Weihuan Wang; Xiaoran Huang; Amad Awadellah; Qing Li; Ann Friedman; William W Xin; Luca Di Martino; Fabio Cominelli; Alex Miron; Ricky Chan; James G Fox; Yan Xu; Xiling Shen; Mathew F Kalady; Sanford Markowitz; Ivan Maillard; John B Lowe; Wei Xin; Lan Zhou Journal: Gastroenterology Date: 2016-09-14 Impact factor: 22.682
Authors: Lik Hang Lee; Marietta Iacucci; Miriam Fort Gasia; Subrata Ghosh; Remo Panaccione; Stefan Urbanski Journal: Can J Gastroenterol Hepatol Date: 2017-01-15
Authors: Gheorghe Hundorfean; Stephen P Pereira; John G Karstensen; Peter Vilmann; Adrian Saftoiu Journal: Gastroenterol Res Pract Date: 2018-05-31 Impact factor: 2.260